OR WAIT null SECS
Eingun James Song, MD, is the director of clinical research for Frontier Dermatology.
November 16, 2026
Video
Head-to-head TYK2 data show that agents within the same mechanistic class may differ meaningfully in speed, depth of clearance, and target selectivity.
Two-year icotrokinra data highlight sustained clearance in difficult-to-treat sites and raise important questions about IL-23–mediated disease memory.
November 09, 2026
Selecting an oral psoriasis therapy requires balancing disease characteristics with efficacy, convenience, comorbidities, and individual patient priorities.
Advances in psoriasis biology are translating key inflammatory pathways into increasingly precise oral treatment targets.